PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Ciclosporin 0.1% Eye Drops (Verkazia) - Allergic conjunctivitis

PAD Profile : Ciclosporin 0.1% Eye Drops (Verkazia) - Allergic conjunctivitis

Keywords :
severe vernal keratoconjunctivitis, keratitis
Brand Names Include :
Verkazia

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Formulations :
  • Eye drops (unit dose)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
12 November 2018
Not Set

This drug has not yet been evaluated by the Surrey and Sussex Prescribing Clinical Network (PCN). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. 

This drug is currently not on the PCN workplan. The PCN will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team formulary pharmacist or chief pharmacist at your acute trust, if you wish to make a submission.

If asked to prescribe, please contact a member of your Medicines Management Team

Associated BNF Codes

11. Eye
11.04.02. Other anti-inflammatory preparations
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More